Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC)-The hunt for effective treatments

J Infect. 2024 May;88(5):106146. doi: 10.1016/j.jinf.2024.106146. Epub 2024 Mar 24.

Authors

Norman B Gaylis¹, Otto O Yang²

Affiliations

¹ President and Director of Arthritis and Rheumatic Disease Specialities, 2801 NE 213th St #801, Aventura 33180, FL, USA. Electronic address: [email protected].
² Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA, USA; Department of Microbiology, Immunology, and Molecular Genetics, University of California-Los Angeles, Los Angeles, CA, USA.

PMID: 38531430
DOI: 10.1016/j.jinf.2024.106146

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / complications
COVID-19* / immunology
Humans
Post-Acute COVID-19 Syndrome*
SARS-CoV-2* / immunology